Development of A9/A10 dopamine neurons during the second and third trimesters in the African green monkey

Disruption in the development of dopamine‐containing neurons has been postulated to underlie several CNS disorders. However, there have been no quantitative studies on the normal development of primate dopamine neurons. Thus, the fetal maturation of primate midbrain dopamine neurons was examined to establish changes that occur in the A9/A10 groups during the second and third trimesters. Eleven fetal African green monkey midbrains were immunostained for tyrosine hydroxylase (TH‐ir) as a marker for dopamine neurons and quantified using stereological techniques (nucleator method). The number and size of defined dopamine neurons and the volume occupied by A9/A10 neurons increased in near linear fashion throughout the term. The estimated number of defined dopamine neurons in each hemisphere rose from ∼50,000 at embryonic day (E) 70 to 225,000 at birth (E165), similar to the adult population. The size and the area occupied by them at birth were, however, well below the estimated adult levels. Additionally, the younger fetal midbrains had far less diversity in dopamine cell volumes compared with older fetuses and adult brains. Until midway through gestation (E81), clusters of apparently immature midbrain TH‐ir cells were observed, but could not be counted. Even though the majority of cells destined to become dopamine neurons are generated in the first trimester, phenotypical maturation of A9 and A10 cell bodies continues steadily throughout gestation and extends well into the postnatal period. These data have relevance to transplantation studies that employ fetal dopaminergic grafts, and to disorders hypothesized to result from damage to developing midbrain dopamine neurons. J. Comp. Neurol. 488:215–223, 2005. © 2005 Wiley‐Liss, Inc.

[1]  P. Carvey,et al.  Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease. , 2003, Frontiers in bioscience : a journal and virtual library.

[2]  Oleg Shupliakov,et al.  Evidence for neurogenesis in the adult mammalian substantia nigra , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Smidt,et al.  Transcription Factors in the Development of Midbrain Dopamine Neurons , 2003, Annals of the New York Academy of Sciences.

[4]  Melitta Schachner,et al.  Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons , 2002, Nature Biotechnology.

[5]  Redmond De Cellular replacement therapy for Parkinson's disease--where we are today? , 2002 .

[6]  R. Roth,et al.  Fear‐like biochemical and behavioral responses in rats to the predator odor, TMT, are dependent on the exposure environment , 2002, Synapse.

[7]  Richard Grondin,et al.  Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. , 2002, Brain : a journal of neurology.

[8]  G. Gerhardt,et al.  Changes in somatodendritic but not terminal dopamine
regulation in aged rhesus monkeys , 2002, Journal of neurochemistry.

[9]  S. Ho,et al.  The aetiology of idiopathic Parkinson's disease , 2001, Molecular pathology : MP.

[10]  D. Ramsden The Nucleic Acid Protocol Handbook. , 2001 .

[11]  M. Grégoire,et al.  Anatomic and Biochemical Correlates of the Dopamine Transporter Ligand 11C-PE2I in Normal and Parkinsonian Primates: Comparison with 6-[18F]Fluoro-L-Dopa , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  M. Palkovits,et al.  Nigrostriatal innervation is preserved in Nurr1-null mice, although dopaminergic neuron precursors are arrested from terminal differentiation. , 2000, Brain research. Molecular brain research.

[13]  H. Singer Current issues in Tourette syndrome , 2000, Movement disorders : official journal of the Movement Disorder Society.

[14]  J. Pierri,et al.  Decreased density of tyrosine hydroxylase–immunoreactive axons in the entorhinal cortex of schizophrenic subjects , 2000, Biological Psychiatry.

[15]  C. Perrone-Capano,et al.  Epigenetic cues in midbrain dopaminergic neuron development , 2000, Neuroscience & Biobehavioral Reviews.

[16]  A. Rosenthal,et al.  Specification of dopaminergic and serotonergic neurons in the vertebrate CNS , 1999, Current Opinion in Neurobiology.

[17]  J. Holden,et al.  Age‐related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys , 1998, The Journal of comparative neurology.

[18]  Monique Ernst,et al.  DOPA Decarboxylase Activity in Attention Deficit Hyperactivity Disorder Adults. A [Fluorine-18]Fluorodopa Positron Emission Tomographic Study , 1998, The Journal of Neuroscience.

[19]  P S Goldman-Rakic,et al.  Widespread origin of the primate mesofrontal dopamine system. , 1998, Cerebral cortex.

[20]  R. Turner,et al.  Dopaminergic Neurons Intrinsic to the Primate Striatum , 1997, The Journal of Neuroscience.

[21]  A. Granholm,et al.  Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum , 1997, Experimental Brain Research.

[22]  J. Fawcett,et al.  The Time Course of Loss of Dopaminergic Neurons and the Gliotic Reaction Surrounding Grafts of Embryonic Mesencephalon to the Striatum , 1996, Experimental Neurology.

[23]  K. Lieb,et al.  Pre- and postnatal development of dopaminergic neuron numbers in the male and female mouse midbrain. , 1996, Brain research. Developmental brain research.

[24]  M. Ernst,et al.  Presynaptic dopaminergic deficits in Lesch-Nyhan disease. , 1996, The New England journal of medicine.

[25]  R. Roth,et al.  Restoration of dopamine transporter density in the striatum of fetal ventral mesencephalon-grafted, but not sham-grafted, MPTP-treated parkinsonian monkeys. , 1996, Cell transplantation.

[26]  D. Rosenberg,et al.  Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices: A tyrosine hydroxylase immunohistochemical analysis , 1995, The Journal of comparative neurology.

[27]  Guido Nikkhah,et al.  Preservation of fetal ventral mesencephalic cells by cool storage: in-vitro viability and TH-positive neuron survival after microtransplantation to the striatum , 1995, Brain Research.

[28]  J. Rosenstein Why Do Neural Transplants Survive? An Examination of Some Metabolic and Pathophysiological Considerations in Neural Transplantation , 1995, Experimental Neurology.

[29]  G. Pardi,et al.  Development of Dopaminergic Neurons in the Human Mesencephalon and in Vitro Effects of Basic Fibroblast Growth Factor Treatment , 1994, Experimental Neurology.

[30]  B. Berger,et al.  Early evidence of catecholaminergic cell groups in 5- and 6-week-old human embryos using tyrosine hydroxylase and dopamine-β-hydroxylase immunocytochemistry , 1991, Neuroscience Letters.

[31]  R. Strecker,et al.  Development of dopaminergic neurons in the human substantia nigra , 1991, Experimental Neurology.

[32]  C. Clough,et al.  Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease. , 1991, Archives of neurology.

[33]  B. Berger,et al.  Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates , 1991, Trends in Neurosciences.

[34]  J. Barker,et al.  Early appearance of tyrosine hydroxylase immunoreactive cells in the mesencephalon of mouse embryos , 1990, International Journal of Developmental Neuroscience.

[35]  H. Gundersen,et al.  Efficient estimation of cell volume and number using the nucleator and the disector , 1990, Journal of microscopy.

[36]  I. Reisert,et al.  Prenatal development of mesencephalic and diencephalic dopaminergic systems in the male and female rat. , 1990, Brain research. Developmental brain research.

[37]  H J Gundersen,et al.  The nucleator , 1988, Journal of microscopy.

[38]  M. Marmot,et al.  Could Parkinson's disease follow intra-uterine influenza?: a speculative hypothesis. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[39]  H. Groenewegen,et al.  The pre- and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat , 1988, Neuroscience.

[40]  D. German,et al.  1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonian syndrome in Macaca fascicularis: Which midbrain dopaminergic neurons are lost? , 1988, Neuroscience.

[41]  S. Haber,et al.  Survival and growth of fetal catecholamine neurons transplanted into primate brain , 1986, Brain Research Bulletin.

[42]  J. Pearson,et al.  Human brainstem catecholamine neuronal anatomy as indicated by immunocytochemistry with antibodies to tyrosine hydroxylase , 1983, Neuroscience.

[43]  P. Rakić,et al.  The time of genesis, embryonic origin and differentiation of the brain stem monoamine neurons in the rhesus monkey. , 1982, Brain research.

[44]  K. Shannak,et al.  Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. , 1981, The New England journal of medicine.

[45]  D. Reis,et al.  Light‐microscopic immunocytochemical localization of tyrosine hydroxylase in prenatal rat brain. II. Late ontogeny , 1981, The Journal of comparative neurology.

[46]  S. Hsu,et al.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[47]  D. Reis,et al.  Immunocytochemical localization of tyrosine hydroxylase in the human fetal nervous system , 1980, The Journal of comparative neurology.

[48]  D. Garver,et al.  Monoamine distribution in primate brain. I. Catecholamine‐containing perikarya in the brain stem of Macaca speciosa , 1975, The Journal of comparative neurology.

[49]  F. Bloom,et al.  Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat. I. Cell differentiation , 1974, The Journal of comparative neurology.

[50]  L. Olson,et al.  Histochemical demonstration and mapping of 5-hydroxytryptamine- and catecholamine-containing neuron systems in the human fetal brain , 1973, Zeitschrift für Anatomie und Entwicklungsgeschichte.

[51]  L. Olson,et al.  Early prenatal ontogeny of central monoamine neurons in the rat: Fluorescence histochemical observations , 2004, Zeitschrift für Anatomie und Entwicklungsgeschichte.

[52]  O. Hansson,et al.  Improving the survival of grafted dopaminergic neurons: a review over current approaches. , 2000, Cell transplantation.

[53]  Konrad Sandau,et al.  Unbiased Stereology. Three‐Dimensional Measurement in Microscopy. , 1999 .

[54]  S. Sesack,et al.  Chapter VI Dopamine systems in the primate brain , 1997 .

[55]  C. Olanow,et al.  The influence of donor age on the survival of solid and suspension intraparenchymal human embryonic nigral grafts. , 1995, Cell transplantation.

[56]  G. Gopinath,et al.  Developing substantia nigra in human: a qualitative study. , 1994, Developmental neuroscience.

[57]  A. Hendrickx,et al.  Prenatal growth in the cynomolgus and rhesus macaque (Macaca fascicularis and Macaca mulatta): A comparison by ultrasonography , 1988, American journal of primatology.

[58]  A. Björklund,et al.  Topography of the monoamine neuron systems in the human brain as revealed in fetuses. , 1973, Acta physiologica Scandinavica. Supplementum.